Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers.

Antimicrobial Agents and Chemotherapy
R MinamiM Nakano

Abstract

This study was designed to determine the influence of aluminum hydroxide and famotidine on the bioavailability of tosufloxacin. Coadministration of aluminum hydroxide reduced the bioavailability of tosufloxacin by 31.6% (P < 0.05). Famotidine did not alter tosufloxacin absorption. To avoid potential treatment failures, the concurrent use of tosufloxacin and aluminum hydroxide should be avoided altogether.

References

May 1, 1978·Chemical & Pharmaceutical Bulletin·M NakanoT Arita
Jan 1, 1992·Clinical Pharmacokinetics·G R GrannemanD Mukherjee
Jun 1, 1992·Antimicrobial Agents and Chemotherapy·J ShimadaS Yamamoto
Dec 1, 1989·Clinical Pharmacology and Therapeutics·D E NixJ J Schentag
Dec 1, 1986·British Journal of Clinical Pharmacology·O U PetringH E Poulsen
Nov 1, 1981·Journal of Pharmacobio-dynamics·K YamaokaT Uno
Nov 1, 1994·Clinical Pharmacology and Therapeutics·P Lehto, K T Kivistö
Jan 1, 1994·British Journal of Clinical Pharmacology·P LehtoP J Neuvonen

❮ Previous
Next ❯

Citations

Sep 29, 2011·Drugs·Ryuichi Ogawa, Hirotoshi Echizen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

International Journal of Clinical Pharmacology Research
I De LepeleireP J De Schepper
Pakistan Journal of Pharmaceutical Sciences
Najma SultanaReeshanul Quraish
Scandinavian Journal of Gastroenterology
Lars FändriksNimish Vakil
© 2022 Meta ULC. All rights reserved